The Thirty Years War that reshaped Europe featured myriad twists and turns. The Krill Wars have, too, with the latest being a final, formal burying of the hatchet between the two principal players, Aker BioMarine and Neptune Technologies and Bioressources.
The long-running krill oil patent dispute between Canada’s Neptune Technologies & Bioressources and Israel-based Enzymotec Ltd. has come to an end, with the firms signing a final and binding patent infringement settlement and license agreement.
French probiotic leader Danone, Swedish dairy firm Skånemejerier and ingredient supplier Probi yesterday closed a three-way probiotic juice deal, bringing the firms one step closer to an international launch of the ProViva brand.
UK-based ReGen Therapeutics has been granted a US patent on its
peptide nutraceutical Colostrinin, which it is planning to
introduce in the North American market as a dietary supplement for
Novogen is blaming lower US sales of its red clover-based
supplements in the first six months of 2004 on consumer confusion
due to the conflicting publicity regarding the safety and efficacy
of HRT and natural menopause products.
Strong demand for red clover-based supplements in Europe and
Australia is driving growth at isoflavones firm Novogen, which
reported a 6 per cent increase in sales of its consumer products
for the six months to end of December 2004.